In NEJM, Lander Lauds Steps at FDA to Build New Regulatory Framework for Genomic Tests

NEW YORK (GenomeWeb) – What makes next-generation sequencing-based diagnostic tests alluring also makes them complicated to regulate, but changes to the regulatory framework could ease the adoption of such tests, the Broad Institute's Eric Lander wrote in a Perspective article in the New England Journal of Medicine this week.